| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |